A Case of Medullary Thyroid Carcinoma in which the Skin Metastasis was Concurrently Present and Response Occurred to Chemotherapy.
- Author:
Won Je CHOI
1
;
Yun Young LEE
;
Soyon KIM
;
Yun Kwon KIM
;
Eun Sil KIM
;
Seung O SEO
;
Jae Hyun JO
;
Seung Min LEE
;
Hyo Jin LEE
Author Information
1. Department of Internal Medicine, National Police Hospital, Seoul, Korea. drsykim@chol.com
- Publication Type:Case Report
- Keywords:
Medullary thyroid carcinoma;
Cutaneous metastases;
Chemotherapy
- MeSH:
Liver;
Lung;
Neoplasm Metastasis;
Prognosis;
Skin;
Thyroid Gland;
Thyroid Neoplasms
- From:Cancer Research and Treatment
2008;40(4):202-206
- CountryRepublic of Korea
- Language:English
-
Abstract:
Medullary thyroid carcinoma accounts for 3% of all thyroid gland malignancies. It commonly metastasizes to liver, lung, and bone. It rarely metastasizes to skin, and only a few such cases have been documented. Cutaneous metastasis suggests a poor prognosis, with a mean survival of 7.5-19 months. The most effective treatment for skin metastasis is complete surgical removal of all local and regional lesions. The response to systemic chemotherapy is typically poor. We report a case of medullary thyroid carcinoma with cutaneous metastases, which responded to chemotherapy.
